CCAAT/enhancer binding protein ε: Changes in function upon phosphorylation by p38 MAP kinase

Blood

Volumn 105, Issue 10, 2005, Pages 3841-3847

  Williamson, Elizabeth A ^a   Williamson, Ian K ^b   Chumakov, Alexey M ^b   Friedman, Alan D ^b   Koeffler, H Phillip ^b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN EPSILON; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; SERINE; THREONINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

EID: 18544381583     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-09-3708     Document Type: Article

References (37)

1. Williamson EA, Xu HN, Gombart AF, et al. Identification of transcriptional activation and repression domains in human CCAAT/enhancer- binding protein ε. J Biol Chem. 1998;273:14796-14804.
2. Chumakov AM, Grillier I, Chumakova E, Chih D, Slater J, Koeffler HP. Cloning of the novel human myeloid-cell-specific C/EBPε transcription factor. Mol Cell Biol. 1997;17:1375-1386.
3. Akira S, Isshiki H, Sugita T, et al. IL-6 and NF-IL6 in acute-phase response and viral infection. EMBO J. 1990;9:1897-1906.
4. Antonson P, Xanthanopoulos K. Molecular cloning, sequence and expression of the human gene encoding CCAAT/enhancer binding protein α (C/EBPα). Biochem Biophys Res Comm. 1995;215:106-113.
5. Cleutjens CBJM, Van Eekelen CCEM, Van Dekken H, et al. The human C/EBPδ (CRP3/CELF) gene: structure and chromosomal localization. Genomics. 1993;16:520-523.
6. Park JS, Luethy JD, Wang MG, et al. Isolation, characterization and chromosomal localization of the human GADD153 gene. Gene. 1992;116:259-267.
7. Buck M, Poli V, Hunter T, Chojkier M. C/EBPβ phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Mol Cell. 2001;8:8807-8816.
8. Chinery R, Brockman JA, Dransfield DT, Coffey RJ. Antioxidant-induced nuclear translocation of CCAAT/enhancer binding protein β. J Biol Chem. 1997;272:30356-30361.
9. Nakajima T, Kinoshita S, Sasagawa T, et al. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci U S A. 1993;90:2207-2211.
10. Piwien-Pilipuk G, Van Mater D, Ross SE, MacDougald OA, Schwartz J. Growth hormone regulates phosphorylation and function of CCAAT/enhancer-binding protein β by modulating Akt and glycogen synthase kinase-3. J Biol Chem. 2001;276:19664-19671.
11. Trautwein C, Van Der Geer P, Karin M, Hunter T, Chojkier M. Protein kinase A and C site-specific phosphorylations of LAP (NF-IL6) modulate its binding affinity to DNA recognition elements. J Clin Invest. 1994;93:2554-2561.
12. Wegner M, Cao Z, Rosenfeld MG. Calcium-regulated phosphorylation within the leucine zipper of C/EBPβ. Science. 1992;256:370-373.
13. Mahoney CW, Shuman J, McKnight SL, Chen H-C, Huang, K-P. Phosphorylation of CCAAT-enhancer binding protein by protein kinase C attenuates site-selective DNA binding. J Biol Chem. 1992;267:19396-19403.
14. Ross SE, Erickson RL, Hemati N, MacDougald OA. Glycogen synthase kinase 3 is an insulin-regulated C/EBPα kinase. Mol Cell Biol. 1999;19:8433-8441.
15. Osada S, Yamamoto H, Nishihara T, Imagawa M. DNA binding specificity of the CCAAT/enhancer-binding protein transcription factor family. J Biol Chem. 1996;271:3891-3896.
16. Yamanaka R, Lekstrom-Himes J, Barlow C, Wynshaw-Boris A, Xanthanopoulos KG. CCAAT/enhancer binding proteins are critical components of the transcriptional regulation of hematopoiesis. Int J Mol Med. 1998;1:213-221.
17. Chih DY, Chumakov AM, Park DJ, Silla AJ, Koeffler HP. Modulation of mRNA expression of a novel human myelold-selective CCAAT/enhancer binding protein gene (C/EBP epsilon). Blood. 1997;90:2987-2994.
18. Morosetti R, Park DJ, Chumakov AM, et al. A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic differentiation. Blood. 1997;90:2591-2600.
19. Akira S, Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev. 1992;127:25-50.
20. Juan TS, Wilson DR, Wilde MD, Darlington GJ. Participation of the transcription factor C/EBP delta in the acute-phase regulation of the human gene for complement component C3. Proc Natl Acad Sci USA. 1993;90:2584-2588.
21. Zhang DE, Hetherington CJ, Meyers S, et al. CCAAT enhancer binding protein (C/EBP) and AML1 (CBFα2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol Cell Biol. 1996;16:1231-1240.
22. Engelman JA, Lisanti MP, Scherer PE. Specific inhibitors of p38 mitogen-activated protein kinase blocks 3T3-L1 adipogenesis. J Biol Chem. 1998;273:32111-32120.
23. Wang XZ, Ron D. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science. 1996;272:1347-1349.
24. Ito W, Ishiguro H, Kurosawa Y. A general method for introducing a series of mutations into cloned DNA using the polymerase chain reaction. Gene. 1991;102:67-70.
25. Verbeek W, Gombart AF, Chumakov AM, Muller C, Friedman AD, Koeffler HP. C/EBPε directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters. Blood. 1999;93:3327-3337.
26. Gombart AF, Kwok SH, Anderson, KL, Yamaguchi Y, Torbett BE, Koeffler HP. Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBPε and PU. 1. Blood. 2003;101:3265-3273.
27. Yamanaka R, Barlow C, Lekstrom-Himes J, et al. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein ε-deficient mice. Proc Natl Acad Sci U S A. 1997;94:13187-13192.
28. Shore P, Whitmarsh AJ, Bhaskaran R, Davis, RJ, Waltho JP, Sharrocks AD. Determinants of DNA-binding specificity of ETS-domain transcription factors. Mol Cell Biol. 1996;15:3338-3349.
29. Strahl T, Gille H, Shaw PE. Selective response of ternary complex factor Sap-1a to different mitogen-activated protein kinase sub-groups. Proc Natl Acad Sci USA. 1996;93:11563-11568.
30. Yang S-H, Shore P, Willingham N, Lakey JH, Sharrocks AD. Targeting of p38 mitogen-activated protein kinase to MEF2 transcription factors. EMBO J. 2002;18:5666-5674.
31. Nick JA, Avdi NJ, Young SK, et al. Selective activation and functional significance of p38a mitogen-activated protein kinase in lipopolysaccharide- stimulated neutrophils. J Clin Invest. 1999;103:851-858.
32. Suzuki K, Hino M, Hato F, Tatsumi N, Kitigawa S. Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-α. Blood. 1999;93:341-349.
33. Allen L-AH, DeLeo FR, Gallois A, Toyoshima S, Suzuki K, Nauseef WM. Transient association of the nicotinamide adenine dinucleotide phosphate oxidase subunits p47 phox and p67 phox with phagosomes in neutrophils from patients with X-linked chronic granulomatous disease. Blood. 1999;93:3521-3530.
34. Gombart AF, Shiohara M, Kwok SH, Agematsu K, Komiyama A, Koeffler HP. Neutrophil-specific granule deficiency: homozygous recessive inheritance of a frameshift mutation in the gene encoding the transcription factor CCAAT/enhancer binding protein-epsilon. Blood. 2001;97:2561-2567.
35. Lekstrom-Himes JA, Dorman SE, Kopar P, Holland SM, Gallin JI. Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein epsilon. J Exp Med. 1999;189:1847-1852.
36. Roberts A, Kim C, Zhen L, et al. Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense. Immunity. 1999;10:183-196.
37. Ambruso DR, Knall C, Abell AN, et al. Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc Natl Acad Sci U S A. 2000;97:4654-4659.